You Searched For "biontech vaccine" and got 19 results
Sort By:
1 min read
Pfizer, BioNTech surge after the US government orders 100 million doses of COVID-19 vaccine
Adding the vaccine "increases the odds that we will have a safe, effective vaccine as soon as the e…
Carmen Reinicke
2 mins read
Moderna, BioNtech surge as COVID-19 vaccine development progresses amid virus spike
BioNtech and Pfizer have already produced millions of doses of its vaccine so it can deliver on pre…
Matthew Fox
5 mins read
The co-founder of BioNTech designed the coronavirus vaccine it made with Pfizer in just a few hours over a single day
BioNTech co-founder Ugur Sahin designed 10 different vaccine candidates over a single day in Januar…
Susie Neilson
1 min read
BioNTech rallies 16% after boosting the sales forecast for its COVID-19 vaccine and projecting sturdy demand ahead
Vaccine demand is likely to persist well into next year, the company said, with more than a billion…
Ethan Wu
3 mins read
Pfizer says its coronavirus vaccine could be ready by this fall, and US testing could start as early as next week
Pfizer partnered with German company BioNTech and is ramping up its coronavirus vaccine testing, sa…
Mia Jankowicz
2 mins read
Europe's drugs regulator speeds up the approval process for Pfizer and BioNTech's COVID-19 vaccine
Europe's drugs regulator has started a "rolling review" of Pfizer and BioNTech's COVID-19 vaccine t…
Kate Duffy
2 mins read
Pfizer and BioNTech begin human trial for COVID-19 vaccine in US
"It is encouraging that we have been able to leverage more than a decade of experience in developin…
PTI
3 mins read
Pfizer claims its newly approved COVID-19 vaccine can survive without sub-zero temperatures for five days
The COVID-19 vaccine being developed by Pfizer and BioNTech has been greenlit by the UK government.…
1 min read
Pfizer and BioNTech shares rise after FDA grants 2 coronavirus vaccines 'fast track' status
The candidates that received fast track status are the most advanced of four potential vaccines bei…
Carmen Reinicke
2 mins read
Moderna sues Pfizer after saying it wouldn't enforce its patents for COVID-19 vaccine technology
Moderna is suing competing vaccine maker Pfizer and its German partner BioNTech, alleging the pharm…
Beatrice Nolan,Grace Kay
1 min read
Pfizer, BioNTech gain after saying they'll submit their COVID-19 vaccine to the FDA for emergency approval
The companies "believe in their capability to distribute the vaccine globally upon approval or auth…
Matthew Fox
1 min read
BioNTech soars after COVID-19 vaccine drives monster earnings beat and stronger guidance
BioNTech saw a more than 7,000% jump in revenue year-over-year from €27 million to €2 billion, driv…
Matthew Fox
1 min read
Pfizer and BioNTech are filing for full approval of their COVID-19 vaccine with the FDA
Full approval by the FDA means the pharma companies will be able to administer vaccines after the p…
Annabelle Williams
2 mins read
BioNTech plans modular vaccine factories in Africa
Berlin, Feb 16 (AP) German vaccine maker BioNTech, which developed the first widely approved shot a…
2 mins read
BioNTech has already started developing a new Omicron version of its COVID-19 vaccine
The German biotech, which makes COVID-19 vaccines with Pfizer, said Monday it doesn't want to "wast…
Mary Hanbury
1 min read
BioNTech's CEO says the world might need new COVID-19 vaccines by mid-2022 to protect against emerging variants
Current COVID-19 vaccines and booster shots may not be enough to protect against future variants of…
Kate Duffy
1 min read
Moderna and Pfizer rebound after FDA authorizes third COVID-19 booster shot for immunocompromised
Year-to-date, shares of BioNTech, Moderna, and Pfizer have surged 357%, 275%, and 28%, respectively.
Matthew Fox
2 mins read
The scientist behind Pfizer's vaccine says people will likely need a 3rd COVID-19 shot and yearly doses
BioNTech's chief medical officer said the COVID-19 vaccine would be similar to the annual flu shot …
Natasha Dailey
1 min read
Pfizer and BioNTech have asked US regulators to make their COVID-19 vaccine available to adolescents ages 12 to 15
The vaccine showed "100 percent efficacy" and triggered a "robust antibody response" in trials with…